Invention Grant
- Patent Title: Compositions and methods for inhibition of the JAK pathway
-
Application No.: US15988920Application Date: 2018-05-24
-
Publication No.: US10556891B2Publication Date: 2020-02-11
- Inventor: Yan Chen , Vanessa Taylor , Hui Li , Rajinder Singh
- Applicant: Rigel Pharmaceuticals, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Klarquist Sparkman, LLP
- Agent Travis Young
- Main IPC: A61K31/506
- IPC: A61K31/506 ; C07D413/12 ; A61K31/155 ; C07D401/14 ; C07D403/12 ; C07D413/04 ; C07D487/08 ; A61K31/5377 ; A61K31/5383 ; A61K31/54 ; A61K31/541 ; A61K31/551 ; A61K45/06 ; C07D419/14 ; C07D471/08 ; C07D487/04 ; C07D491/08 ; A61K31/538 ; A61K31/55 ; A61K31/675 ; C07D413/14 ; C07D471/04 ; C07D487/10 ; C07D498/04 ; C07F9/6558 ; A61K31/5415 ; A61K31/635 ; C07D451/02
Abstract:
Disclosed are compounds of formula I, compositions containing them, and methods of use for the compounds and compositions in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK 2 and JAK3, are therapeutically useful.
Public/Granted literature
- US20180265503A1 COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY Public/Granted day:2018-09-20
Information query
IPC分类:
